About us Our Products Press Centre Our people Investor Relations Human Resources Contact Us
 
 
Home > Investor Relations
 
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 20122012/02/03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 20112012/01/05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 20112011/12/02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 20112011/11/03
VOLUNTARY ANNOUNCEMENT - LANSEN SIGNS EXCLUSIVE MARKETING AND DISTRIBUTION AGREEMENT WITH ETHYPHARM FOR KETOPROFEN/OMEPRAZOLE SR IN THE PRC2011/10/26
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 20112011/10/03
Interim Financial Highlights 20112011/09/28
Financial Highlights 20102011/09/28
LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM2011/09/06
LETTER TO SHAREHOLDERS AND CHANGE REQUEST FORM2011/09/06
LETTER TO NEW SHAREHOLDERS AND REPLY FORM2011/09/06
NOTIFICATION OF PUBLICATION OF 2011 INTERIM REPORT2011/09/06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 20112011/09/02
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 20112011/08/25
DATE OF BOARD MEETING2011/08/11
 57  1/4  1234Next...4
Copyright © 2005-2012 Lansen    Corporate profile  |  Legal Notices  |  Contact Us  |  Professional Link
As with all prescription drugs, please follow your doctor's instructions